Cognitive in the treatment of Alzheimer's disease
We recommend
At the Crossroads: 5 Options for Alzheimer's Disease Pharmacotherapy
Currently, we have 5 basic options for the pharmacotherapy of Alzheimer's disease. Is memantine, one of the three cholinesterase inhibitors, or combination therapy the most effective? A review article by Japanese and American authors evaluates the literature on the safety and efficacy of cognitive treatments for Alzheimer's disease.
Memantine, Acetylcholinesterase Inhibitors, and Their Combination in the Treatment of Alzheimer's Disease − Findings from Meta-Analyses
Is memantine, an acetylcholinesterase inhibitor (donepezil), or their combination more advantageous…
Alzheimer's Disease – Another Pandemic on the Horizon?
Due to the COVID-19 pandemic, other current problems often get pushed into the background. One of…
Articles on this topic
Memantine in Dementia Therapy – Current Findings and Possible Future Applications
Memantine is an inhibitor of NMDA receptors, which are pathologically activated by excessive…
How Does Memantine Currently Stand in Alzheimer's Disease and Other Dementias
A comprehensive meta-analysis from 2019 examined the effect and safety of administering…
Memantine and Donepezil – Unity is Strength
Memantine and donepezil are both used in the therapy of Alzheimer's disease (AD). However, how…
Memantine Eases Daily Life for Patients and Caregivers
What is the efficacy and safety of memantine in patients with Alzheimer's disease in routine…
Alzheimer's Disease: Diagnosis Step by Step in 4 Points
Alzheimer's disease is the most common cause of dementia. With the aging population, this…
Reimbursement vs. Indication: Are They Clashing in Alzheimer's Disease?
Data from clinical trials and recommended procedures do not always align with insurance…
Journal articles Comorbidities of Alzheimer‘s disease – results of a multicentric observational COSMOS study in the Slovak Republic
Alzheimerova demencia (AD) patrí medzi najviac invalidizujúce ochorenia prevažne staršej populácie....
Journal articles Cerebrospinal fluid ratio of phosphorylated tau protein and beta amyloid predicts amyloid PET positivity
Současná diagnostická kritéria Alzheimerovy nemoci zdůrazňují vedle klinické diagnózy také vyšetření...
Journal articles Transcranial sonography of the medial temporal lobe in Alzheimer’s disease patients
V současné době žije celosvětově okolo 50 milionů pacientů s demencí, přičemž odhady ukazují, že...
Journal articles Neuropsychiatric symptoms as early manifestation of Alzheimer’s disease
Neuropsychiatrické symptomy (NPS) jsou heterogenní skupina změn v osobnosti a chování, které...
1
2
Most read on this topic
Journal on this topic
Related topic
- Possible prevention of Alzheimer’s disease
- Memantine and Donepezil – Unity is Strength
- Neuropsychiatric symptoms as early manifestation of Alzheimer’s disease
- Memantine Eases Daily Life for Patients and Caregivers
- Memantine in Dementia Therapy – Current Findings and Possible Future Applications
- Cerebrospinal fluid ratio of phosphorylated tau protein and beta amyloid predicts amyloid PET positivity
Journal on this topic
Related topic